voriconazole has been researched along with Chromoblastomycosis in 16 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (6.25) | 29.6817 |
2010's | 14 (87.50) | 24.3611 |
2020's | 1 (6.25) | 2.80 |
Authors | Studies |
---|---|
Badali, H; De Hoog, GS; Illnait-Zaragozi, MT; Meis, JF; Najafzadeh, MJ | 1 |
Bonfietti, L; de Camargo, ZP; de Carvalho, JA; de Souza Carvalho Melhem, M; de Souza Lima, BJF; Guevara, A; Hagen, F; Hahn, RC; Nery, AF; Rodrigues, AM; Vicente, VA | 1 |
Chen, X; Hu, Y; Liu, K; Lu, Y; Mao, Z; Qi, X; Sun, H; Wu, Z; Yang, Y; Zhou, X | 1 |
Cosenza, FD; Criado, PR; Ferreira, PS; Junior, WB | 1 |
Almeida-Paes, R; Brito-Santos, F; Coelho, RA; do Valle, ACF; Figueiredo-Carvalho, MHG; Freitas, DFS; Gutierrez-Galhardo, MC; Meyer, W; Silva, JVDS; Trilles, L; Zancopé-Oliveira, RM | 1 |
Kikuchi, N; Nishiyama, K; Ohashi, T; Ohtsuka, M; Suzutani, T; Yamamoto, T | 1 |
Hamblin, MR; Hu, Y; Huang, X; Lu, S; Mylonakis, E; Xi, L; Zhang, J | 1 |
Aguirre-Garza, M; Carolina Rojas, O; González, GM; León-Cachón, RB; Moreno-Treviño, MG; Pérez-Maya, AA | 1 |
Belda, W; Careta, MF; Criado, PR; Martins, JE; Rivitti, EA; Spina, R; Valente, NY | 1 |
Calvo, E; Guarro, J; Hernández, P; Mayayo, E; Pastor, FJ | 1 |
Kamei, K; Nishimura, K; Sugaya, K; Sugiyama, Y; Suzuki, Y; Tokura, Y; Yaguchi, T | 1 |
Chu, J; Meehan, S; Patel, R; Patel, U | 1 |
Hu, Y; Li, X; Liang, Y; Lu, C; Xi, L; Yang, Y; Zhang, J | 1 |
Fan, YM; Huang, WM; Li, W; Yang, YP; Zhou, Y | 1 |
Badali, H; Curfs-Breuker, I; de Hoog, GS; Deng, S; Liao, W; Meis, JF; Najafzadeh, MJ; Pan, B; Yang, L | 1 |
Hamza, SH; Mercado, PJ; Skelton, HG; Smith, KJ | 1 |
16 other study(ies) available for voriconazole and Chromoblastomycosis
Article | Year |
---|---|
In vitro activities of eight antifungal drugs against 55 clinical isolates of Fonsecaea spp.
Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Ascomycota; Caspofungin; Chromoblastomycosis; Drug Resistance, Fungal; Echinocandins; Fluconazole; Humans; In Vitro Techniques; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Nitriles; Pyridines; Pyrimidines; Triazoles; Voriconazole | 2010 |
Molecular epidemiology and clinical-laboratory aspects of chromoblastomycosis in Mato Grosso, Brazil.
Topics: Amplified Fragment Length Polymorphism Analysis; Antifungal Agents; Brazil; Chromoblastomycosis; Diabetes Mellitus, Type 2; Humans; Itraconazole; Middle Aged; Molecular Epidemiology; Terbinafine; Voriconazole | 2022 |
Photodynamic therapy combined with antifungal drugs against chromoblastomycosis and the effect of ALA-PDT on Fonsecaea in vitro.
Topics: Aminolevulinic Acid; Antifungal Agents; Ascomycota; China; Chromoblastomycosis; DNA, Fungal; Female; Humans; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Photochemotherapy; Skin; Terbinafine; Voriconazole | 2019 |
Longitudinal melanonychia due to voriconazole therapy during treatment of chromoblastomycosis.
Topics: Antifungal Agents; Chromoblastomycosis; Humans; Male; Middle Aged; Nail Diseases; Voriconazole | 2018 |
Molecular identification and antifungal susceptibility profiles of clinical strains of Fonsecaea spp. isolated from patients with chromoblastomycosis in Rio de Janeiro, Brazil.
Topics: Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Ascomycota; Brazil; Caspofungin; Chromoblastomycosis; DNA, Fungal; DNA, Intergenic; Echinocandins; Female; Humans; Itraconazole; Lipopeptides; Male; Microbial Sensitivity Tests; Middle Aged; Voriconazole | 2018 |
A case of chromoblastomycosis caused by Fonsecaea pedrosoi in a patient with rheumatoid arthritis.
Topics: Antifungal Agents; Arthritis, Rheumatoid; Ascomycota; Biopsy; Chromoblastomycosis; Humans; Male; Middle Aged; Risk Factors; Skin; Treatment Outcome; Voriconazole | 2015 |
Photodynamic therapy combined with terbinafine against chromoblastomycosis and the effect of PDT on Fonsecaea monophora in vitro.
Topics: Aminolevulinic Acid; Antifungal Agents; Ascomycota; Chromoblastomycosis; Drug Therapy, Combination; Humans; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Naphthalenes; Photochemotherapy; Skin; Terbinafine; Treatment Outcome; Voriconazole | 2015 |
Phenotypic and molecular identification of Fonsecaea pedrosoi strains isolated from chromoblastomycosis patients in Mexico and Venezuela.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Ascomycota; Chromoblastomycosis; DNA, Ribosomal Spacer; Female; Humans; Itraconazole; Male; Mexico; Microbial Sensitivity Tests; Middle Aged; Mitosporic Fungi; Molecular Sequence Data; Phenotype; Sequence Analysis, DNA; Skin; Venezuela; Voriconazole | 2015 |
Extensive long-standing chromomycosis due to Fonsecaea pedrosoi: three cases with relevant improvement under voriconazole therapy.
Topics: Adult; Aged; Antifungal Agents; Ascomycota; Chromoblastomycosis; Humans; Male; Middle Aged; Pyrimidines; Triazoles; Voriconazole | 2011 |
Antifungal therapy in an athymic murine model of chromoblastomycosis by Fonsecaea pedrosoi.
Topics: Animals; Antifungal Agents; Ascomycota; Chromoblastomycosis; Itraconazole; Male; Mice; Mice, Nude; Mitosporic Fungi; Naphthalenes; Pyrimidines; Terbinafine; Triazoles; Voriconazole | 2011 |
[Chromoblastomycosis caused by Fonsecaea monophora].
Topics: Administration, Oral; Antifungal Agents; Ascomycota; Base Sequence; Chromoblastomycosis; Humans; Hyperthermia, Induced; Japan; Male; Middle Aged; Philippines; Pyrimidines; RNA, Fungal; RNA, Ribosomal; Treatment Outcome; Triazoles; Voriconazole | 2011 |
Subcutaneous dematiaceous fungal infection.
Topics: Acute Kidney Injury; Aged; Amphotericin B; Antifungal Agents; Chromoblastomycosis; Combined Modality Therapy; Costa Rica; Diagnosis, Differential; Humans; Immunocompromised Host; Immunosuppressive Agents; Itraconazole; Kidney Transplantation; Leg; Male; Phaeohyphomycosis; Pneumonia; Pyrimidines; Soil Microbiology; Triazoles; Voriconazole | 2011 |
A refractory case of chromoblastomycosis due to Fonsecaea monophora with improvement by photodynamic therapy.
Topics: Aminolevulinic Acid; Antifungal Agents; Ascomycota; China; Chromoblastomycosis; Humans; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Naphthalenes; Photochemotherapy; Pyrimidines; Terbinafine; Treatment Outcome; Triazoles; Voriconazole | 2012 |
Chromoblastomycosis caused by Fonsecaea: clinicopathology, susceptibility and molecular identification of seven consecutive cases in Southern China.
Topics: Administration, Oral; Aged; Aged, 80 and over; Antifungal Agents; Ascomycota; China; Chromoblastomycosis; DNA, Fungal; Female; Hospitals, Teaching; Humans; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Sequence Data; Naphthalenes; Pyrimidines; Sequence Analysis, DNA; Terbinafine; Treatment Outcome; Triazoles; Voriconazole | 2013 |
In vitro antifungal susceptibility of Cladophialophora carrionii, an agent of human chromoblastomycosis.
Topics: Amphotericin B; Antifungal Agents; Ascomycota; Caspofungin; Chromoblastomycosis; Echinocandins; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Nitriles; Pyridines; Pyrimidines; Triazoles; Voriconazole | 2013 |
An unusual dematiaceous fungal infection of the skin caused by Fonsecaea pedrosoi: a case report and review of the literature.
Topics: Adult; Antifungal Agents; Ascomycota; Chromoblastomycosis; Humans; Itraconazole; Male; Pyrimidines; Skin; Triazoles; Voriconazole | 2003 |